Interleukin-1 Gene-511 CT Polymorphism and the Risk of Alzheimer's Disease in a Polish Population

被引:13
作者
Klimkowicz-Mrowiec, A. [1 ,2 ]
Marona, M. [1 ]
Wolkow, P. [3 ]
Maruszak, A. [4 ]
Styczynska, M. [4 ]
Barcikowska, M. [4 ]
Zekanowski, C. [4 ]
Szczudlik, A. [1 ]
Slowik, A. [1 ]
机构
[1] Jagiellonian Univ, Dept Neurol, Sch Med, PL-31503 Krakow, Poland
[2] Jagiellonian Univ, Sch Med, Dept Neurol, Univ Hosp, PL-31503 Krakow, Poland
[3] Jagiellonian Univ, Sch Med, Dept Pharmacol, PL-31503 Krakow, Poland
[4] Polish Acad Sci, Med Res Ctr, Dept Neurodegenerat Disorders, Warsaw, Poland
关键词
Alzheimer's disease; Interleukin-1; Polymorphism; Risk factor; Polish population; ASSOCIATION; ONSET; IL-1-ALPHA; IL-1-BETA; DEMENTIA; BETA;
D O I
10.1159/000259460
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Interleukin-1 is a potent proinflammatory cytokine involved in the pathophysiology of Alzheimer's disease (AD). We genotyped IL-1 beta (-511 C/T) and the apolipoprotein E (APOE) common polymorphisms in a large case-controlled study in a Polish population. We included 332 patients with late-onset AD and 220 controls without any neurological deficit, cognitive complaints and history of neurological diseases, aged >= 65 years. The distribution of the IL-1 beta (-511 C/T) genotypes was similar to that in the controls (AD: C/C = 45.8%, C/T = 44.6%, T/T = 9.6% vs. controls: C/C = 53.9%, C/T = 38.3%, T/T = 7.3%, p > 0.05). Our study confirms previous reports that APOE epsilon 4 is strongly related to the risk of AD (odds ratio = 6.60, 95% confidence interval 4.19-10.41). APOE status did not affect the distribution of the studied IL-1 beta polymorphism. The IL-1 beta (-511 C/T) polymorphism is not a risk factor for late-onset AD in a Polish population. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:461 / 464
页数:4
相关论文
共 29 条
  • [1] Evidence for glial-mediated inflammation in aged APPSW transgenic mice
    Benzing, WC
    Wujek, JR
    Ward, EK
    Shaffer, D
    Ashe, KH
    Younkin, SG
    Brunden, KR
    [J]. NEUROBIOLOGY OF AGING, 1999, 20 (06) : 581 - 589
  • [2] Cytokine IL-1 beta but not IL-1 alpha promoter polymorphism is associated with Alzheimer disease in a population from the Canary Islands, Spain
    Deniz-Naranjo, M. C.
    Munoz-Fernandez, C.
    Alemany-Rodriguez, M. J.
    Perez-Vieitez, M. C.
    Aladro-Benito, Y.
    Irurita-Latasa, J.
    Sanchez-Garcia, F.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (10) : 1080 - 1084
  • [3] Association between the interleukin-1β polymorphisms and Alzheimer's disease: A systematic review and meta-analysis
    Di Bona, Danilo
    Plaia, Antonella
    Vasto, Sonya
    Cavallone, Luca
    Lescai, Francesco
    Franceschi, Claudio
    Licastro, Federico
    Colonna-Romano, Giuseppina
    Lio, Domenico
    Candore, Giuseppina
    Caruso, Calogero
    [J]. BRAIN RESEARCH REVIEWS, 2008, 59 (01) : 155 - 163
  • [4] Biologic basis for interleukin-1 in disease
    Dinarello, CA
    [J]. BLOOD, 1996, 87 (06) : 2095 - 2147
  • [5] Association of an interleukin 1α polymorphism with Alzheimer's disease
    Du, Y
    Dodel, RC
    Eastwood, BJ
    Bales, KR
    Gao, F
    Lohmüller, F
    Müller, U
    Kurz, A
    Zimmer, R
    Evans, RM
    Hake, A
    Gasser, T
    Oertel, WH
    Griffin, WST
    Paul, SM
    Farlow, MR
    [J]. NEUROLOGY, 2000, 55 (04) : 480 - 483
  • [6] FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198
  • [7] GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611
  • [8] Grimaldi LME, 2000, ANN NEUROL, V47, P361, DOI 10.1002/1531-8249(200003)47:3<361::AID-ANA12>3.0.CO
  • [9] 2-N
  • [10] Association of interleukin-1 polymorphisms with Alzheimer's disease in Australia
    Hedley, R
    Hallmayer, J
    Groth, DM
    Brooks, WS
    Gandy, SE
    Martins, RN
    [J]. ANNALS OF NEUROLOGY, 2002, 51 (06) : 795 - 797